These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7201839)

  • 1. [On the meaning of psychometrically operationalized therapeutic effects in the treatment of brain insufficiency phenomena caused by old age demonstrated by the "Nürnberger-Alters-Inventar" (author's transl)].
    Oswald WD; Matejcek M; Lukaschek K; Dennler HJ; Oswald B
    Arzneimittelforschung; 1982; 32(5):584-90. PubMed ID: 7201839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1978; 28(9):1529-30. PubMed ID: 383104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
    Biel ML; Seus R; Struppler A
    Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
    Ordosgoitia H; Castro C; Carbayeda M; Labella T
    An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of alcoholic predelirium during treatment with piracetam: results of serial psychometric tests (author's transl)].
    Meyer JG; Forst R; Meyer-Wahl L
    Dtsch Med Wochenschr; 1979 Jun; 104(25):911-4. PubMed ID: 446321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of treatment on performance and self-appraisal in geriatric patients (author's transl)].
    Oswald WD; Lang E
    MMW Munch Med Wochenschr; 1980 Jan; 122(2):59-62. PubMed ID: 6767923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eutergin in the treatment of chronic cerebrovascular disturbance patterns (author's transl)].
    Prosenz P
    Aktuelle Gerontol; 1980 Jun; 10(6):245-51. PubMed ID: 6109460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of pharmacological treatment in the compensation of vertigo].
    Pons Rocher F
    An Otorrinolaringol Ibero Am; 1999; 26(3):271-91. PubMed ID: 10394686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trial of piracetam in children with cerebral organic mental deficiency].
    Rösler HD; Kleinpeter U; Gehrke R; Hinz G; Krause G
    Psychiatr Neurol Med Psychol (Leipz); 1977 Jun; 29(6):350-9. PubMed ID: 335419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain among children and adolescents: restrictions in daily living and triggering factors.
    Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
    Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective estimate of the nursing cost of autonomy impairment and cost benefit in clinical trials: feasibility and application of piracetam in demented elderly patients.
    Vlietinck R; Van Loon H; Van de Broele H; Tormans G
    Adv Ther; 1993; 10(5):226-44. PubMed ID: 10172000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Hungarian version of the Nuremberg Geronto-psychological Inventory].
    Pék G; Fülöp T
    Orv Hetil; 1991 Oct; 132(42):2319-22. PubMed ID: 1945368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The protective effect of piracetam during delivery].
    Klink F; Grosspietzsch R; von Klitzing L; Oberheuser F
    Fortschr Med; 1979 Dec; 97(46):2163-5. PubMed ID: 535860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
    Dennler HJ; Bachmann H
    MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly.
    Maugeri D; Testaì M; Santangelo A; Abbate S; Bennati E; Bonanno MR; Lo Giudice F; Mamazza C; Panebianco P
    Arch Gerontol Geriatr; 2005; 40(1):1-5. PubMed ID: 15531018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.